Cargando…
Development of Diabetes Type 3 After SARS-COV-2 Pancreatic B Cell Injury
SARS-COV-2 has caused millions of deaths in less than one year, yet little is known about the long-term consequences survivors may suffer. The novel coronavirus uses the ACE2 receptor to infect human cells, allowing it to target organ systems with such receptors including the respiratory, cardiovasc...
Autores principales: | Zayas, Francisco Jose, Hernandez-Negron, Marianne, Garcia, Michelle Marie Mangual |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Oxford University Press
2021
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8090012/ http://dx.doi.org/10.1210/jendso/bvab048.760 |
Ejemplares similares
-
SUN-155 Clinical Experience of SGLT2 Inhibitors in a Hispanic Population: Should We Consider Its Use as Add-On Treatment?
por: Zayas, Francisco, et al.
Publicado: (2019) -
SAT-684 A Deadly Triad: Coexistence of Acute Pancreatitis, Hypertryglyceridemia and Diabetic Ketoacidosis
por: Torres Torres, Marina T, et al.
Publicado: (2020) -
Hyperglycemia, Hypertriglyceridemia and Acute Pancreatitis in COVID-19 Infection
por: Torres, Marina Torres, et al.
Publicado: (2021) -
SUN-124 Latent Autoimmune Diabetes of the Adult (LADA): Is It Gestational Diabetes?
por: Cruz Dardiz, Nicolas, et al.
Publicado: (2019) -
SAT-679 Autoimmune Hypoglycemia: A Treatment Challenge
por: Santana, Nadyeschka Angelique Rivera, et al.
Publicado: (2020)